Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1707-1712, April 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, X.
Right arrow Articles by Campbell, I. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, X.
Right arrow Articles by Campbell, I. G.

Allelotyping of Endometriosis with Adjacent Ovarian Carcinoma Reveals Evidence of a Common Lineage1

Xiuxian Jiang, Sarah J. Morland, Andrew Hitchcock, Eric J. Thomas and Ian G. Campbell2

Obstetrics and Gynecology, University of Southampton, Princess Anne Hospital, Southampton SO16 5YA [X. J., S. J. M., E. J. T., I. G. C.], and Department of Histopathology, Southampton General Hospital, Southampton SO16 6YD [A. H.], United Kingdom

Endometriosis is a common gynecological disease in which tissue similar to the endometrium proliferates at sites outside the uterine cavity. Malignant transformation of endometriosis to endometrioid and clear cell ovarian carcinomas has been documented in histological studies, but no molecular genetic evidence exists to support that endometriosis is the clonal precursor of such malignancies. We examined 14 cases of endometriosis synchronous with ovarian cancer for loss of heterozygosity on 12 chromosome arms, X chromsome inactivation, and TP53 mutation to determine whether they shared genetic alterations. In all four of the cases where the carcinoma had arisen within endometriosis and in five of the seven cases where the carcinoma was adjacent to the endometriosis, common genetic lesions were detected, consistent with a common lineage. A TP53 mutation was also detected in one case of endometriosis adjacent to carcinoma. These findings support the numerous histological observations that endometrioid and clear cell ovarian carcinomas may arise through malignant transformation of endometriotic lesions.

1 Supported by grants from Wellbeing and The Wessex Medical Trust.

2 To whom reprints should be addressed, at Obstetrics and Gynaecology, University of Southampton, Level F, Princess Anne Hospital, Coxford Road, Southampton SO16 5YA, UK.

Received 9/18/97. Accepted 2/18/98.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Yamaguchi, M. Mandai, S. Toyokuni, J. Hamanishi, T. Higuchi, K. Takakura, and S. Fujii
Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress
Clin. Cancer Res., January 1, 2008; 14(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. D. Wren, Y. Wu, and S.-W. Guo
A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium
Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Vigano, E. Somigliana, I. Chiodo, A. Abbiati, and P. Vercellini
Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis
Hum. Reprod. Update, January 1, 2006; 12(1): 77 - 89.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. G. Campbell, S. E. Russell, W. A. Phillips, D. A. Levine, and J. Boyd
PIK3CA Mutations in Ovarian Cancer
Clin. Cancer Res., October 1, 2005; 11(19): 7042 - 7043.
[Full Text] [PDF]


Home page
Cancer Res.Home page
I. G. Campbell, S. E. Russell, D. Y. H. Choong, K. G. Montgomery, M. L. Ciavarella, C. S. F. Hooi, B. E. Cristiano, R. B. Pearson, and W. A. Phillips
Mutation of the PIK3CA Gene in Ovarian and Breast Cancer
Cancer Res., November 1, 2004; 64(21): 7678 - 7681.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y.-Y. Hsieh, C.-C. Chang, F.-J. Tsai, C.-C. Lin, J.-M. Chen, and C.-H. Tsai
Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis
Mol. Hum. Reprod., October 1, 2004; 10(10): 713 - 717.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. Lattuada, P. Vigano, E. Somigliana, A. Abbiati, M. Candiani, and A.M. Di Blasio
Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis
Mol. Hum. Reprod., September 1, 2004; 10(9): 651 - 654.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
R. Varma, T. Rollason, J. K Gupta, and E. R Maher
Endometriosis and the neoplastic process
Reproduction, March 1, 2004; 127(3): 293 - 304.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. Harada, A. Kaponis, T. Iwabe, F. Taniguchi, G. Makrydimas, N. Sofikitis, M. Paschopoulos, E. Paraskevaidis, and N. Terakawa
Apoptosis in human endometrium and endometriosis
Hum. Reprod. Update, January 1, 2004; 10(1): 29 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
K.-H. Tung, M. T. Goodman, A. H. Wu, K. McDuffie, L. R. Wilkens, L. N. Kolonel, A. M. Y. Nomura, K. Y. Terada, M. E. Carney, and L. H. Sobin
Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study
Am. J. Epidemiol., October 1, 2003; 158(7): 629 - 638.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Lin, X. Zhang, and Y. Chen
Mutagen sensitivity as a susceptibility marker for endometriosis
Hum. Reprod., October 1, 2003; 18(10): 2052 - 2057.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. C. Modesitt, G. Tortolero-Luna, J. B. Robinson, D. M. Gershenson, and J. K. Wolf
Ovarian and Extraovarian Endometriosis-Associated Cancer
Obstet. Gynecol., October 1, 2002; 100(4): 788 - 795.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S M Ismail, S Vandeginste, and R W Shaw
An unusually aggressive case of endometriosis showing p53 expression
J. Clin. Pathol., May 1, 2001; 54(5): 396 - 398.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Auersperg, A. S. T. Wong, K.-C. Choi, S. K. Kang, and P. C. K. Leung
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology
Endocr. Rev., April 1, 2001; 22(2): 255 - 288.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
S.W. Baxter, E.J. Thomas, and I.G. Campbell
GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer
Carcinogenesis, January 1, 2001; 22(1): 63 - 66.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Sato, H. Tsunoda, M. Nishida, Y. Morishita, Y. Takimoto, T. Kubo, and M. Noguchi
Loss of Heterozygosity on 10q23.3 and Mutation of the Tumor Suppressor Gene PTEN in Benign Endometrial Cyst of the Ovary: Possible Sequence Progression from Benign Endometrial Cyst to Endometrioid Carcinoma and Clear Cell Carcinoma of the Ovary
Cancer Res., December 1, 2000; 60(24): 7052 - 7056.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
X. Matias-Guiu, E. Bussaglia, L. Catasus, H. Lagarda, E. Gras, P. Machin, J. Prat, W. M. Lin, and C. Y. Muller
Correspondence re: W. M. Lin et al., Loss of Heterozygosity and Mutational Analysis of the PTEN/MMAC1 Gene in Synchronous Endometrial and Ovarian Carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
Clin. Cancer Res., April 1, 2000; 6(4): 1598 - 1600.
[Full Text]


Home page
Clin. Cancer Res.Home page
L. Kopelovich, D. E. Henson, A. F. Gazdar, B. Dunn, S. Srivastava, G. J. Kelloff, and P. Greenwald
Surrogate Anatomic/Functional Sites for Evaluating Cancer Risk: An Extension of the Field Effect
Clin. Cancer Res., December 1, 1999; 5(12): 3899 - 3905.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.